ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1216

Sjogren’s Syndrome-Associated Transcripts Show Correlation with Objective Measures of Dryness

John A. Ice1, Indra Adrianto1, Astrid Rasmussen1, Kiely Grundahl2, Michelle L. Joachims3, Graham B. Wiley1, Jennifer A. Kelly1, Glen D. Houston4, David M. Lewis4, Lida Radfar5, Donald U. Stone6,7, Barbara M. Segal8, Nelson L. Rhodus9, Joel M. Guthridge3, James Chodosh10,11, Raj Gopalakrishnan12, Andrew J.W. Huang13, Pamela J Hughes14, Michael D. Rohrer15, Judith A. James1,16,17, Courtney G. Montgomery1, R. Hal Scofield1,17,18, Patrick Gaffney1, Kathy L. Sivils3 and Christopher J. Lessard1, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 5Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 6King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 7Department of Ophthalmology, Johns Hopkins University, Baltimore, MD, 8Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 9Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 10Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 11Harvard Medical School, Boston, MA, 12Diagnostic and Biological Sciences, Division of Oral Pathology, University of Minnesota School of Dentistry, Minneapolis, MN, 13Department of Ophthalmology and Visual Sciences, Washington University, St. Louis, MO, 14Department of Oral and Maxillofacial Surgery, Oregon Health & Science University School of Dentistry, Portland, OR, 15Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, MN, 16Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 17Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 18US Department of Veterans Affairs Medical Center, Oklahoma City, OK

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: classification criteria, dry eyes and genomics, Gene Expression, Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Genetics, Genomics and Proteomics - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Sjögren’s syndrome (SS) is a chronic autoimmune disorder in which exocrine dysfunction can lead to chronic, debilitating dryness. Expression studies in SS have identified the dysregulated expression of coding and non-coding transcripts enriched in innate and adaptive immune response pathways, yet their relationship to clinical features of SS remains poorly understood. By applying statistical approaches to RNA sequencing (RNA-seq) data for 3748 differentially expressed (DE; FC>2 or <0.5, q<0.05) transcripts in SS, we sought to identify transcripts whose expression correlates with objective dryness measures used in the 2002 American-European Consensus Group (AECG) SS classification criteria, including whole unstimulated salivary flow (WUSF), lissamine green (LiG) staining, and Schirmer’s (Sch) tear migration.

Methods: Normalized expression data from a whole blood SS RNA-seq study was obtained for 57 cases and 11 healthy controls who underwent multidisciplinary clinical evaluation for the 2002 AECG classification criteria. Objective dryness measures (WUSF, LiG, & Sch) were normalized by log2 transformation and correlation analysis (Spearman for WUSF and LiG; Pearson for Sch) was performed for each clinical measure against all 3748 DE transcripts. Both r or ρ and a FDR-corrected p-value, or q-value, were calculated. Significantly correlated transcripts were defined by q<0.05.

Results: For WUSF, the significant positive correlation between WUSF rate and the expression of 2 non-coding transcripts was observed: the small Cajal body-specific RNA 5 (SCARNA5; s=0.50, q=0.018) and the uncharacterized antisense lncRNA RP11-137H2.4 (s=0.50, q=0.018). For LiG, positive correlation was observed for 31 transcripts (0.42<s<0.51, 0.017<q<0.05) mostly represented by interferon-inducible (IFI) protein-coding genes (e.g. IFIT3, OAS3, and IRF7), although the pseudogene ZDHHC4P1 and its neighboring IFI gene EPSTI1 showed significant positive correlation. For LiG, the only negatively correlated transcript was the sodium bicarbonate transporter SCL4A10 (s=-0.43, q=0.045). For Sch, 3 transcripts (CARD16, HMGB2, and BLC2A1) were negatively correlated (-0.51<s<-0.49, 0.018<q<0.019), while IQCH was positively correlated (s=0.49, q=0.019).

Conclusion: We have identified SS-associated transcripts whose expression correlates with clinical measures of dryness. For WUSF, the ncRNA SCARNA5 is situated within an intron of the Crohn’s disease-associated gene autophagy-related 16-like 1 (ATG16L1). Although IFI genes have previously shown correlation with WUSF, the ZDHHC4P1 pseudogene could regulate neighboring SS-associated IFI gene EPSTI1. For Sch, CARD16 is a caspase inhibitor that influences apoptotic responses that induces NF-kB activation in inflammation, while BLC2A1 has been shown to slow apoptotic responses. Further transcript characterization will allow us to assess their potential as biomarkers or surrogates of objective clinical measures for SS.


Disclosure: J. A. Ice, None; I. Adrianto, None; A. Rasmussen, None; K. Grundahl, None; M. L. Joachims, None; G. B. Wiley, None; J. A. Kelly, None; G. D. Houston, None; D. M. Lewis, None; L. Radfar, None; D. U. Stone, None; B. M. Segal, None; N. L. Rhodus, None; J. M. Guthridge, None; J. Chodosh, None; R. Gopalakrishnan, None; A. J. W. Huang, None; P. J. Hughes, None; M. D. Rohrer, None; J. A. James, None; C. G. Montgomery, None; R. H. Scofield, Eli Lilly and Company, 5,UCB, 5; P. Gaffney, None; K. L. Sivils, None; C. J. Lessard, None.

To cite this abstract in AMA style:

Ice JA, Adrianto I, Rasmussen A, Grundahl K, Joachims ML, Wiley GB, Kelly JA, Houston GD, Lewis DM, Radfar L, Stone DU, Segal BM, Rhodus NL, Guthridge JM, Chodosh J, Gopalakrishnan R, Huang AJW, Hughes PJ, Rohrer MD, James JA, Montgomery CG, Scofield RH, Gaffney P, Sivils KL, Lessard CJ. Sjogren’s Syndrome-Associated Transcripts Show Correlation with Objective Measures of Dryness [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/sjogrens-syndrome-associated-transcripts-show-correlation-with-objective-measures-of-dryness/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sjogrens-syndrome-associated-transcripts-show-correlation-with-objective-measures-of-dryness/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology